Association between lymph node evaluation for colon cancer and node positivity over the past 20 years

JAMA

Volumn 306, Issue 10, 2011, Pages 1089-1097

  Parsons, Helen M ^a   Tuttle, Todd M ^b,d   Kuntz, Karen M ^c   Begun, James W ^c   McGovern, Patricia M ^c   Virnig, Beth A ^c,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROCTOCOLECTOMY; RACE DIFFERENCE; SURVIVAL TIME; TOTAL COLON RESECTION; TUMOR LOCALIZATION;

EID: 80052702147     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1285     Document Type: Article

References (32)

1. Institute of Medicine. Performance Measurement: Accelerating Improvement. Washington, DC: National Academies Press; 2006.
2. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433-441. (Pubitemid 47073566)
3. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93(6):439-445. (Pubitemid 44651266)
4. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244(4):602-610.
5. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21(15):2912-2919. (Pubitemid 46621841)
6. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26(2):179-189. (Pubitemid 34127497)
7. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149-2154. (Pubitemid 350106653)
8. Yoshimatsu K, Ishibashi K, Umehara A, et al. How many lymph nodes should be examined in Dukes' B colorectal cancer? determination on the basis of cumulative survival rate. Hepatogastroenterology. 2005; 52(66):1703-1706. (Pubitemid 41745615)
9. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6(4):325-344.
10. Fleming ID, Cooper JS, Henson DE, eds, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott; 1997.
11. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York, NY: Wiley; 1997.
12. Compton CC, Fielding LP, Burgart LJ, et al; College of American Pathologists Consensus Statement. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979-994.
13. Nelson H, Petrelli N, Carlin A, et al; National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93(8):583-596.
14. Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47(8):1269-1284. (Pubitemid 39180201)
15. Simunovic M, Baxter NN. Lymph node counts in colon cancer surgery: lessons for users of quality indicators. JAMA. 2007;298(18):2194-2195. (Pubitemid 350106659)
16. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum. 2010;53(1):65-70.
17. Surveillance, Epidemiology, and End Results (SEER) Program research data (1973-2007). National Cancer Institute. http://seer.cancer.gov. Accessed August 17, 2011.
18. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50(8):939-945. (Pubitemid 27423524)
19. Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 2005; 61(2):426-431. (Pubitemid 40164437)
20. ASCO/NCCN quality measures: breast and colorectal cancers (2007 update). American Society of Clinical Oncology. http://www.asco.org/ASCO /Downloads/Cancer%20Policy%20and%20Clinical%20Affairs/NCCN/ ASCO%20NCCN%20Quality%20Measures%20table%20web%20posting%20with%20CoC%200507. pdf. Accessed February 22, 2011.
21. Peng CJ, Lee KL, Ingersoll GM. An introduction to logistic regression analysis and reporting. J Educ Res. 2002;96(1):3-14.
22. Understanding the changes from the sixth to the seventh edition of the AJCC Cancer Staging Manual. American Joint Committee on Cancer. http://www.cancerstaging.org/staging/changes2010.pdf. Accessed August 19, 2011.
23. How is colorectal cancer staged? American Cancer Society. http://www.cancer.org/cancer /colonandrectumcancer/detailedguide/colorectal -cancer-staged. Accessed August 5, 2011.
24. Baxter NN. Is lymph node count an ideal quality indicator for cancer care? J Surg Oncol. 2009;99(4):265-268.
25. Okabe S, Shia J, Nash G, et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg. 2004;8(8):1032-1039.
26. Nivatvongs S, Rojanasakul A, Reiman H, et al. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum. 1991; 34(4):323-328.
27. Liefers G-J, Cleton-Jansen A-M, van de Velde CJH, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339(4):223-228. (Pubitemid 28350164)
28. Ho SB, Hyslop A, Albrecht R, et al. Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase- PCR analysis for carcinoembryonic antigen. Clin Cancer Res. 2004;10(17):5777- 5784. (Pubitemid 39180955)
29. Bernini A, Spencer M, Frizelle S, et al. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes. Cancer Detect Prev. 2000;24(1):72-79. (Pubitemid 30152742)
30. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008;100(18):1310-1317.
31. Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296(23):2815-2822. (Pubitemid 44969181)
32. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389-394. (Pubitemid 43342192)